Acadia pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that on november 8, 2024, the compensation committee of acadia's board of directors (the “committee”) granted inducement awards consisting of non-qualified stock options to purchase 70,571 shares of common stock and 40,731 restricted stock units (“rsus”) to twenty-three new employees under acadia's 2024 inducement plan. the compensation committee approved the awards as an inducement material to the new employ.
ACAD Ratings Summary
Quant
ACAD Quant Ranking
Sector
Industry
Quant Rating
Quant Score